Intrinsic reactivity of tamoxifen and toremifene metabolites with DNA

Breast Cancer Research and Treatment

Volumn 50, Issue 2, 1998, Pages 135-141

  Hellmann Blumberg, Utha ^a   Cartner, Maralee G ^a   Wurz, Gregory T ^a   DeGregorio, Michael W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

DNA adducts; Metabolites; Postlabeling; Tamoxifen; Toremifene

Indexed keywords

4 HYDROXYNORTAMOXIFEN; ALPHA HYDROXYTAMOXIFEN; CHLORINE; DOUBLE STRANDED DNA; DRUG METABOLITE; PHENANTHRENE; PHOSPHORUS 32; TAMOXIFEN; TOREMIFENE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DNA ADDUCT; DRUG DNA INTERACTION; HUMAN; LIVER CANCER; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; THIN LAYER CHROMATOGRAPHY; ULTRAVIOLET IRRADIATION;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHROMATOGRAPHY, LIQUID; DNA ADDUCTS; FEMALE; HUMANS; LIVER NEOPLASMS; TAMOXIFEN; TOREMIFENE; ULTRAVIOLET RAYS;

EID: 0031689863     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006002324995     Document Type: Article

References (18)

1. Higginson J, Gelmann EP (eds): Scientific Review of Tamoxifen. In: Seminars in Oncology 24, No. 1, Suppl. 1, 1997
2. Davies R, Oreffo VIC, Martin EA, Festing MFW, White INH, Smith LL, Styles JA: Tamoxifen causes gene mutations in the livers of lambda/lacI transgenic rats. Cancer Res 57: 1288-1293, 1997
3. Phillips DH, Carmichael PL, Hewer A, Cole KJ, Hardcastle IR, Poon GK, Keogh A, Strain AJ: Activation of tamoxifen and its metabolite α-hydroxytamoxifen to DNA-binding products: comparisons between human, rat and mouse hepatocytes. Carcinogenesis 17: 89-94, 1996
4. Potter GA, McCague R, Jarman M: A mechanistic hypothesis for DNA adduct formation by tamoxifen following hepatic oxidative metabolism. Carcinogenesis 15: 439-442, 1994
5. Randerath K, Moorthy B, Mabon M, Sriram P: Tamoxifen: evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite. Carcinogenesis 15: 2087-2094, 1994
6. Moorthy H, Sriram P, Randerath E, Randerath K: Effects of cytochrome P450 inducers on tamoxifen genotoxicity on female mice in vivo. Biochem Pharmacol 53: 663-669, 1997
7. Sambrock J, Fritsch EF, Maniatis T: Molecular Cloning. A Laboratory Manual. 2nd ed. Cold Spring Harbor Laboratory Press, 1989
8. Wilbur BJ, Benz CC, DeGregorio MW: Quantitation of tamoxifen, 4-hydroxytamoxifen, and N-desmethyltamoxifen in human plasma by high performance liquid chromatography. Anal Lett 18 (B15): 1915-1924, 1985
9. Wilson S, Ruenitz PC: Structural characterization and biological effects of photocyclized products of tamoxifen irradiation. J Pharmaceut Sci 82: 571-574, 1993
10. Lien EA, Solheim E, Lea OA, Lundgren S, Kvinnsland S, Ueland PE: Distribution of 4-hydroxy-N-desmethyltamoxifen and other tamoxifen metabolites in human biological fluids during tamoxifen treatment. Cancer Res 49: 2175-2183, 1989
11. Robinson SP, Langan-Fahey SM, Jordan CV: Implications of tamoxifen metabolism in the athymic mouse for the study of antitumor effects upon human breast cancer xenografts. Eur J Cancer Clin Oncol 25: 1769-1776, 1989
12. Hard GC, Iatropoulos MJ, Jordan K, Radi L, Kaltenberg OP, Imondi AR, Williams GM: Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats. Cancer Res 53: 4534-4541, 1993
13. Sipila H, Kangas L, Vuorilehto, Kalapudas A, Eloranta M, Sodervall M, Toivola R Anttila M: Metabolism of toremifene in the rat. J Steroid Biochem 36: 211-215, 1990
14. Phillips DH, Hewer A, White INH, Farmer PB: Co-chromatography of a tamoxifen epoxide-deoxyguanylic acid adduct with a major DNA adduct formed in the livers of tamoxifen trealed rats. Carcinogenesis 15: 793-795, 1994
15. Agarval R, Yagi H, Jerina DM, Dipple A: Benzo[c]phenanthrene 3,4-dihydrol 1,2 epoxide adducts in native and denatured DNA. Carcinogenesis 17: 1773-1776, 1996
16. Mehta P, Church K, Williams J, Chen F-X, Encell L, Shuker DE, Gold B: The design of agents to control DNA methylation adducts. Enhanced major groove methylation of DNA by an N-methyl-N-nitrosourea functionalized neutral red intercalator. Chem Res Toxicol 9: 939-948, 1996
17. Mani C, Kupfer D: Cytochrome P-450-mediated activation and irreversible binding of the antiestrogen tamoxifen to proteins in rat and human liver: possible involvement of flavin-containing monooxygenases in tamoxifen activation. Cancer Res 51: 6052-6058, 1991
18. Mani C, Pearce R, Parkinson A, Kupfer D: Involvement of cytochrome P450 3A in catalysis of tamoxifen activation and covalent binding to rat and human liver microsomes. Carcinogenesis 15: 2715-2720, 1994